NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Single Lipiflow Treatment to Reduce Pharmacologic Burden in DED

Enrolling By InvitationNA

Sponsor: Dunes Eye Consultants

Conditions: MGD-Meibomian Gland Dysfunction

Interventions: Thermal Vectored Pulsation

Countries: United States

Purpose: To evaluate the efficacy of vectored thermal pulsation treatment in subjects with a history of dry eye disease currently using a topical immunomodulator medication.

Eligibility overview

Sex: ALL

Age: 25 Years to 65 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* No prior history of meibomian gland treatment procedures LipiFlow, TearCare, or I-Lux
* lifitegrast or cyclosporine eye drops daily for a period of at least one year but not exceeding five years
* Meibograpy documneted retention of at least 50% of meibomian glands.

Exclusion Criteria:

* evidence of meibomian gland dropout exceeding 50%
* ocular rosacea,
* ocular surgery within the preceding three months
* prior in-office thermal meibomian gland treatment
* ocular trauma within preceding three months
* ocular herpetic infection
* chronic or recurrent inflammation
* eyelid abnormalities affecting lid function ocular surface abnormalities compromising corneal integrity (eg, epithelial basement membrane dystrophy, corneal burn)
* pregnant

Locations (1)

Dakota Dunes, South Dakota, United States